Oligomerix, Inc.
Pharmaceutical company · White Plains, New York, United States
Oligomerix, Inc. is a pharmaceutical company headquartered in White Plains, New York, United States. It has received 13 US government small-business research awards (SBIR/STTR) from health agencies, $21 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $75,000 sold in a notice filed in 2024.
Oligomerix at a glance
What does Oligomerix do?
US government research funding
13 SBIR/STTR small-business research awards from US health agencies, $20.6 million in total (2007 to 2025). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $75,000 sold (2024).
Frequently asked questions about Oligomerix
Where is Oligomerix headquartered?
Oligomerix, Inc. is headquartered in White Plains, New York, United States.
What does Oligomerix do?
Oligomerix, Inc. is a pharmaceutical company.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.